In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
Investor's Business Daily on MSN12h
Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly ReviewMost indexes hit new highs during Thanksgiving week despite President-elect Trump's tariff threats. Nvidia woes helped curb ...
Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.
My 85-year-old mother-in-law had a mild heart attack a few days ago. She didn’t immediately take the nitroglycerin she had on hand. She has a pacemaker, and it ...
Pharmaceutical Technology on MSN7h
EMA launches ESMP for better management of drug shortages in EUThe ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.
The head of MI6 says British security will be "jeopardised" if Putin is allowed to succeed in Ukraine, as he warned the spy agency has already uncovered a Russian sabotage campaign in Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback